HealthFirst Talks: COVID-19 Trends: Facts, Misinformation and Late-Breaking News

With vaccines rolling out around the globe, the “end” of the COVID-19 pandemic may be in sight – but there are still plenty of hot topics to tackle in exploring how the world has responded and shifted in the wake of this uncertain era.

On this episode of HealthFirst Talks, Dr. Scott A. Cohen of the Bassett Healthcare Network and infection prevention specialist Dr. Fiona Collins acted as expert panelists, sharing their front-line insights about the faces, misinformation and late-breaking news surrounding what many hope will prove the pandemic’s closing chapter.

One of the central issues surrounds the vaccines, themselves. Many people are unsure about the vaccines’ safety or efficacy, particularly since those available were accelerated through the approval pipeline so quickly. There are also lingering questions about which vaccine is “better” and how they differ.

Cohen and Collins dove into this topic, explaining how money and a streamlined approval process empowered a vaccine to get into the arms of people more quickly than ever before.

The duo also touched on a range of other topics, such as how the vaccines were actually researched and produced, the practicalities of the rollout and overcoming supply chain challenges, and where the world might go from here both in terms of future vaccines and healthcare, overall.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Recent Episodes

Denials are no longer a slow leak in the revenue cycle—they’re a fast-moving, rule-shifting game controlled by payers, and hospitals that don’t model denial patterns in real time end up budgeting around losses they could have prevented. PayerWatch’s four-digit, client-verified ROI in 2024 shows what happens when a hospital stops reacting claim by…

Health insurers love to advertise themselves as guardians of care, but the real story often begins when a patient’s life no longer fits neatly into a spreadsheet. In oncology especially, “coverage” isn’t a bureaucratic checkbox—it’s the fragile bridge between a treatment that finally works and a relapse that can undo years of grit…

In “Fighting for Coverage,” a patient describes a double war: the physical fight to stay alive and the bureaucratic fight to prove to an insurer that her life is worth the cost. Her account spotlights a core tension in the U.S. system—coverage decisions are increasingly shaped by prior authorizations and desk-based reviewers who…